Clinical Trials
2 trialsNCT07123662 2026-05-28
γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
Guangzhou Bio-gene Technology Co., Ltd
Phase EARLY_PHASE1 Withdrawn
NCT06522373 2026-05-15
Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
M.D. Anderson Cancer Center
Phase 1 Withdrawn